(Reuters) – A U.S. appeals court on Friday rejected a novel strategy adopted by drug company Allergan PLC to shield patents from review by an administrative court by transferring them to a Native American tribe. The U.S. Court of Appeals for the Federal Circui... More »
A U.S. judge on Monday invalidated patents on Allergan Plc's dry-eye medicine Restasis on grounds that the patents cover ideas that are obvious, sending shares of the pharmaceutical company down 3.5 percent. More »
Allergan Plc said on Thursday it reached a settlement with InnoPharma Inc, one of the four generic drugmakers challenging the patents for its dry eye medication Restasis in federal court. More »
Democratic U.S. Senator Claire McCaskill on Thursday said she drafted a bill stating that tribal sovereign immunity cannot be used to block U.S. Patent and Trademark Office review of a patent. More »
A Native American tribe holding patents for drugmaker Allergan Plc (AGN.N) on Friday moved to dismiss a case brought by generic drug company Mylan NV (MYL.O) challenging the patents. More »
Nokia (NOKIA.HE) will start to book additional revenue from the current quarter after a ruling by an arbitration court on payments from South Korea's LG Electronics (066570.KS) for using its smartphone patents. More »
U.S. Senator Sherrod Brown said on Friday a deal that drugmaker Allergan Plc made with a Native-American tribe to shield patents "rips off consumers" and cannot "become the new normal." More »
A Nokia logo is seen at the company’s headquarters in Espoo, Finland, May 5, 2017. REUTERS/Ints Kalnins Telecoms network equipment maker Nokia and Chinese smartphone maker Xiaomi Technology have signed a patent licensing agreement, the companies said on Wednes... More »
MUMBAI India has given private assurances that it will not grant licences allowing local firms to override patents and make cheap copies of drugs by big Western drugmakers, a U.S. business advocacy group said. The comments were revealed in a submission last mo... More »
HELSINKI Nokia (NOKIA.HE) and Samsung (005930.KS) are expected to settle their two-year patent dispute within days, with analysts forecasting a one-time payment of hundreds of millions of euros for the Finnish company. Nokia entered into a binding arbitration ... More »
